Fouzia Laghrissi-Thode

Fouzia is board certified in Psychiatry and holds Doctorate in Medicine from the University of Tours School of Medicine in France. She is currently Chief Executive Officer of DalCor Pharmaceuticals. In her previous roles she led the global product and portfolio strategy of the cardiovascular, metabolism and renal therapeutic areas at AstraZeneca and Roche. She has more than 20 years of pharmaceutical industry leadership experience in U.S. and Europe through working in clinical development, global strategic marketing, business development, licensing and M&A.